High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption

被引:1
|
作者
Drouin-Chartier, Jean-Philippe [1 ,2 ,3 ]
Tremblay, Andre J. [1 ]
Bergeron, Jean [2 ,3 ]
Lamarche, Benoit [4 ]
Couture, Patrick [1 ,2 ,3 ]
机构
[1] Laval Univ, Dept Med, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
[2] Laval Univ, CHU Quebec, Dept Med, Lipid Clin, Quebec City, PQ, Canada
[3] Laval Univ, CHU Quebec, Dept Med, Lipid Res Ctr, Quebec City, PQ, Canada
[4] Laval Univ, Sch Nutr, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Homozygous familial hypercholesterolemia; Lipoprotein apheresis; Dextran sulfate adsorption; Triglyceride; LDL-Cholesterol; CORONARY-HEART-DISEASE; LDL RECEPTOR GENE; CARDIOVASCULAR-DISEASE; FRIEDEWALD FORMULA; CHOLESTEROL; PLASMA; MUTATION; HYPERLIPOPROTEINEMIA; APOLIPOPROTEIN(A); POPULATION;
D O I
10.1016/j.atherosclerosis.2018.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Maximizing the acute reduction of LDL-cholesterol (C) and lipoprotein (a) (Lp(a)) concentrations in patients with homozygous familial hypercholesterolemia (HoFH) is the main goal of lipoprotein apheresis (LA). The objective of this study was to examine how the pre-LA serum TG concentrations influence the efficacy of LA to acutely reduce LDL-C and Lp(a) concentrations in HoFH patients. Methods: Data from 1761 LA treatments of HoFH patients (n = 10) and compound heterozygous patients (n = 5) collected between 2008 and 2016 were analyzed. These data included the pre-and post-LA concentrations of LDL-C, TGs and Lp(a); volume of filtered plasma; type of LA system used (dextran sulfate adsorption (DSA) or heparin-induced extracorporeal LDL precipitation (HELP)); and interval between treatments. Results: A significant association between the pre-LA TG concentrations and acute LA-induced reduction in LDL-C, modified by the type of LA system used, was observed (p pre-LA TG quartile*LA system =.04). Using the DSA system, the acute reduction of the LDL-C concentrations was attenuated by 3.9% when the preLA TG concentrations were > 2.09 mmol/L vs. <= 0.93 mmol/L (highest vs. lowest quartiles: =59.4% vs. =63.3%, p =.007). Using the HELP system, no significant difference was observed in the reduction of LDL-C between the highest and the lowest quartiles of serum TGs (=65.8% vs. =66.4%, p =.9). No association was observed between pre-LA TG concentrations and acute LA-induced decrease in Lp(a) (p =.2). Conclusions: The efficacy of LA is inversely associated with pre-LA TG concentrations in HoFH patients who used the DSA system instead of the HELP system. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 24 条
  • [1] Impact of lipoprotein apheresis with dextran-sulfate adsorption on the expression of genes involved in cardiovascular health in the blood of patients with homozygous familial hypercholesterolemia
    Drouin-Chartier, Jean-Philippe
    Tremblay, Andre J.
    Bergeron, Jean
    Laflamme, Nathalie
    Lamarche, Benoit
    Couture, Patrick
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (01) : 104 - 107
  • [2] Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia
    Duell, Paul Barton
    Warden, Bruce A. A.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 : 12 - 17
  • [3] Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review
    Luirink, Ilse K.
    Determeijer, Jim
    Hutten, Barbara A.
    Wiegman, Albert
    Bruckert, Eric
    Schmitt, Claus P.
    Groothoff, Jaap W.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (01) : 31 - 39
  • [4] Low Density Lipoprotein Apheresis in Pediatric Patients With Homozygous Familial Hypercholesterolemia
    Coker, Mahmut
    Ucar, Sema Kalkan
    Simsek, Damla Goksen
    Darcan, Sukran
    Bak, Mustafa
    Can, Sule
    THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (02) : 121 - 128
  • [5] Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia
    Drouin-Chartier, Jean-Philippe
    Tremblay, Andre J.
    Bergeron, Jean
    Pelletier, Maude
    Laflamme, Nathalie
    Lamarche, Benoit
    Couture, Patrick
    JOURNAL OF CLINICAL APHERESIS, 2016, 31 (04) : 359 - 367
  • [6] DECREASE OF THYROID-HORMONES IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DURING DEXTRAN SULFATE LOW-DENSITY-LIPOPROTEIN APHERESIS
    PINTUS, S
    PINTUS, P
    PIRAS, C
    LOVISELLI, A
    MUNTONI, S
    JOURNAL OF CLINICAL APHERESIS, 1994, 9 (02) : 124 - 125
  • [7] Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis
    Galiano, Matthias
    Hammersen, Johanna
    Sauerstein, Katja
    Blessing, Holger
    Ruemmele, Petra
    Purbojo, Ariawan
    Schoeber, Martin
    Moosmann, Julia
    Raffelsbauer, Gunter
    Heibges, Andreas
    Klingel, Reinhard
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (03) : 163 - 171
  • [8] Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion
    Ogura, Masatsune
    Makino, Hisashi
    Kamiya, Chizuko
    Yoshimatsu, Jun
    Soran, Handrean
    Eatough, Ruth
    Perrone, Giuseppina
    Harada-Shiba, Mariko
    Stefanutti, Claudia
    ATHEROSCLEROSIS, 2016, 254 : 179 - 183
  • [9] CHANGES IN LIPOPROTEIN(A), LDL-CHOLESTEROL AND APOLIPOPROTEIN-B IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH DEXTRAN SULFATE LDL-APHERESIS
    LASUNCION, MA
    TERUEL, JL
    ALVAREZ, JJ
    CARRERO, P
    ORTUNO, J
    GOMEZCORONADO, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (12) : 819 - 826